APA

Gao Q., Meijer M. J. W., Schlüter U. G., van Hogezand R. A., van der Zon J. M., van den Berg M., van Duijn W., Lamers C. B. H. W. & Verspaget H. W. (20070822). Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease. : Inflammatory bowel diseases.

Chicago

Gao Qiang, Meijer Martin J W, Schlüter Ulrike G, van Hogezand Ruud A, van der Zon Johanna M, van den Berg Marlies, van Duijn Wim, Lamers Cornelis B H W and Verspaget Hein W. 20070822. Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease. : Inflammatory bowel diseases.

Harvard

Gao Q., Meijer M. J. W., Schlüter U. G., van Hogezand R. A., van der Zon J. M., van den Berg M., van Duijn W., Lamers C. B. H. W. and Verspaget H. W. (20070822). Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease. : Inflammatory bowel diseases.

MLA

Gao Qiang, Meijer Martin J W, Schlüter Ulrike G, van Hogezand Ruud A, van der Zon Johanna M, van den Berg Marlies, van Duijn Wim, Lamers Cornelis B H W and Verspaget Hein W. Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease. : Inflammatory bowel diseases. 20070822.